scholarly article | Q13442814 |
P356 | DOI | 10.1023/A:1015971429942 |
P698 | PubMed publication ID | 2813273 |
P2093 | author name string | H L Fung | |
G A Brazeau | |||
P2860 | cites work | Legitimate Indications for Intramuscular Injections | Q39779648 |
An in vitro model to evaluate muscle damage following intramuscular injections | Q44165651 | ||
Polyethylene glycol as a solvent for diazepam: bioavailability and clinical effects after intramuscular administration, comparison of oral, intramuscular and rectal administration, and precipitation from intravenous solutions | Q44763807 | ||
Solubilization by cosolvents III: Diazepam and benzocaine in binary solvents. | Q51827264 | ||
Solubilization by cosolvents I: organic solutes in propylene glycol-water mixtures. | Q52430866 | ||
The loss of creatine phosphokinase (CK) from intramuscular injection sites in rabbits. A predictive tool for local toxicity | Q66918892 | ||
Intramuscular injection-site complications | Q67357053 | ||
Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purity | Q69551330 | ||
Muscular toxicity of polyols. IV | Q70628841 | ||
Solubilization by cosolvents II: Phenytoin in binary and ternary solvents | Q70757120 | ||
Response of dogs to subcutaneous injections of various concentrations of propylene glycol with water | Q71288327 | ||
Hemolysis study of aqueous polyethylene glycol 400, propylene glycol and ethanol combinations in vivo and in vitro | Q71361758 | ||
A study of the polyethylene glycols as vehicles for intramuscular and subcutaneous Injection | Q75995902 | ||
The toxicology of the polyethylene glycols | Q80725909 | ||
P433 | issue | 9 | |
P304 | page(s) | 766-771 | |
P577 | publication date | 1989-09-01 | |
P1433 | published in | Pharmaceutical Research | Q7180737 |
P1476 | title | Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems | |
P478 | volume | 6 |
Q46441768 | Acute changes in muscle blood flow and concomitant muscle damage after an intramuscular administration. |
Q55361692 | Approach-aversion in calves following injections. |
Q93929665 | Assessment of the myotoxicity of pharmaceutical buffers using an in vitro muscle model: effect of pH, capacity, tonicity, and buffer type |
Q74602159 | Current perspectives on pain upon injection of drugs |
Q39020837 | If Euhydric and Isotonic Do Not Work, What Are Acceptable pH and Osmolality for Parenteral Drug Dosage Forms? |
Q47798379 | Impact of intramuscular administration of lipid-soluble and water-soluble vehicles into regenerating muscle at the distinct phases of skeletal muscle regeneration |
Q39531684 | In vitro assessment of new embolic liquids prepared from preformed polymers and water-miscible solvents for aneurysm treatment |
Q74628270 | In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery |
Q38303446 | Longitudinal analysis of gene expression in porcine skeletal muscle after post-injection local injury |
Q35698278 | Solubilizing excipients in oral and injectable formulations |
Search more.